Lineage Cell Therapeutics (LCTX) Shares Outstanding (Diluted) (2014 - 2026)
Lineage Cell Therapeutics' Shares Outstanding (Diluted) came in at 261.47 million for Q2 2026, up 14.5% from 228.36 million a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Lineage Cell Therapeutics (LCTX) Shares Outstanding (Diluted) (2014 - 2026) Analysis & Trends
For FY2025, Lineage Cell Therapeutics' Shares Outstanding (Diluted) was 230.12 million, up 14.9% from FY2024.
- Shares Outstanding (Diluted) has increased in each of the last 11 years, with a five-year compound annual growth rate of 8.9% (FY2020 to FY2025).
- Going back by year, Shares Outstanding (Diluted) was 200.19 million in FY2024 (+15.9%), 172.66 million in FY2023 (+1.7%), 169.79 million in FY2022 (+1.3%) and 167.62 million in FY2021 (+11.8%).
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2014.
- Year-over-year, Shares Outstanding (Diluted) has increased for 43 consecutive quarters, with growth averaging 16.8% over the last eight quarters.
- Across the past five years, year-over-year growth in Shares Outstanding (Diluted) ran from 0.3% in Q1 2023 to 23.6% in Q1 2025.
- Business Quant data shows LCTX's Shares Outstanding (Diluted) at 261.18 million (Q1 2026), 230.12 million (Q4 2025) and 228.85 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | Lineage Cell Therapeutics | 240.26 Mn | 38.67 Mn | - | 261.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 261.47 Mn |
| Mar 31, 2026 | 261.18 Mn |
| Dec 31, 2025 | 230.12 Mn |
| Sep 30, 2025 | 228.85 Mn |
| Jun 30, 2025 | 228.36 Mn |
| Mar 31, 2025 | 226.05 Mn |
| Dec 31, 2024 | 200.19 Mn |
| Sep 30, 2024 | 188.84 Mn |
| Jun 30, 2024 | 188.81 Mn |
| Mar 31, 2024 | 182.91 Mn |
| Dec 31, 2023 | 172.66 Mn |
| Sep 30, 2023 | 174.87 Mn |
| Jun 30, 2023 | 170.59 Mn |
| Mar 31, 2023 | 170.13 Mn |
| Dec 31, 2022 | 169.79 Mn |
| Sep 30, 2022 | 169.79 Mn |
| Jun 30, 2022 | 169.73 Mn |
| Mar 31, 2022 | 169.65 Mn |
| Dec 31, 2021 | 167.62 Mn |
| Sep 30, 2021 | 167.62 Mn |
API Access
Lineage Cell Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LCTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "LCTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=LCTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();